16th Jan 2017 17:15
GlaxoSmithKline plc (the 'Company')
Transaction Notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||
a) | Name | Ms C Thomas | ||||||
b) | Position/status | SVP, HR | ||||||
c) | Initial notification/ amendment | Initial notification | ||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | GlaxoSmithKline plc | ||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 | ||||||
b) | Nature of the transaction | Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on shares held in the Deferred Annual Bonus Plan Post-Tax. | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information
Aggregated volume Price |
70.692 £15.7149
| ||||||
e) | Date of the transaction | 2017-01-12 | ||||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||||
Related Shares:
Glaxosmithkline